At a glance
- Originator Tokyo University of Agriculture and Technology
- Class
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 Mar 1995 No-Development-Reported for Atherosclerosis in Japan (Unknown route)